14-74551141-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000428.3(LTBP2):āc.1609C>Gā(p.Pro537Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_000428.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP2 | NM_000428.3 | c.1609C>G | p.Pro537Ala | missense_variant | 7/36 | ENST00000261978.9 | NP_000419.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP2 | ENST00000261978.9 | c.1609C>G | p.Pro537Ala | missense_variant | 7/36 | 1 | NM_000428.3 | ENSP00000261978.4 | ||
LTBP2 | ENST00000556690.5 | c.1609C>G | p.Pro537Ala | missense_variant | 7/35 | 5 | ENSP00000451477.1 | |||
LTBP2 | ENST00000553939.5 | n.1609C>G | non_coding_transcript_exon_variant | 7/36 | 5 | ENSP00000452110.1 | ||||
LTBP2 | ENST00000557425.1 | n.333C>G | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000152 AC: 38AN: 250676Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135706
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461582Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727118
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74370
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2024 | The c.1609C>G (p.P537A) alteration is located in exon 7 (coding exon 7) of the LTBP2 gene. This alteration results from a C to G substitution at nucleotide position 1609, causing the proline (P) at amino acid position 537 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2022 | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 537 of the LTBP2 protein (p.Pro537Ala). This variant is present in population databases (rs770862437, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with LTBP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1431338). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at